Prosecution Insights
Last updated: October 04, 2026
Application No. 18/963,834

APPLICATION OF FRUITING BODY OF LYOPHYLLUM DECASTES IN PREPARING LYOPHYLLUM DECASTES FOOD OR LIPID-LOWERING DRUGS

Non-Final OA §102§112
Filed
Nov 29, 2024
Priority
Dec 08, 2023 — CN 202311686854.5
Examiner
CHEN, CATHERYNE
Art Unit
Tech Center
Assignee
Lanzhou New District Qindong Agricultural Investment Development Co. Ltd.
OA Round
1 (Non-Final)
37%
Grant Probability
At Risk
1-2
OA Rounds
2y 4m
Est. Remaining
55%
With Interview

Examiner Intelligence

Grants only 37% of cases
37%
Career Allowance Rate
296 granted / 791 resolved
-22.6% vs TC avg
Strong +18% interview lift
Without
With
+18.0%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
57 currently pending
Career history
841
Total Applications
across all art units

Statute-Specific Performance

§101
14.3%
-25.7% vs TC avg
§103
41.3%
+1.3% vs TC avg
§102
18.4%
-21.6% vs TC avg
§112
19.4%
-20.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 791 resolved cases

Office Action

§102 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Claims 1-6 are pending and examined on the merits. Information Disclosure Statement The information disclosure statement (IDS) submitted on 12/19/2024 is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. Claim Objections Claim 4 is objected to because of the following informalities: Claim 4, line 4 has extra dash between “15-20”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-6 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In Claims 1 and 6, the phrase performing a “granulation, a polishing, and a first drying in turn” is not understood. What is being granulated, polished, and first dried? What is “in turn”? In Claim 1, what is “performing a second drying…in turn”? In Claim 1, the term “mass” is indefinite because the mass of a chemical does not change. It is inherent with the chemical. Do you mean weight? In Claim 3, the “500 g: (400-450) mL: (40-50) mL” is indefinite because one does not know what is the ratio and why is the parentheses present. Is it part of the claim? For a ratio to make sense, the ratio should be in the same measurement unit. Please amend. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 6 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Liu et al. (from IDS, CN 113061194 A). Liu et al. teaches a method of preparing lycopyllum decastes sporocarp polysaccharide comprising dry powder of sporocarp extracted with absolute ethyl alcohol, removed absolute ethyl alcohol and extract with water, dried the alcohol precipitate, and redissolved precipitate with distilled water, and freeze dried to obtain lycophyllum decastes sporocarp polysaccharide (Abstract). Conclusion No claim is allowed. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to CATHERYNE CHEN whose telephone number is (571)272-9947. The examiner can normally be reached on Monday-Friday 9-5:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice . If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anand U Desai can be reached on 571-272-0947. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Catheryne Chen Examiner Art Unit 1655 /ANAND U DESAI/Supervisory Patent Examiner, Art Unit 1655
Read full office action

Prosecution Timeline

Nov 29, 2024
Application Filed
Sep 22, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12741000
TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING PSORIASIS, PREPARATION METHOD THEREFOR AND USE THEREOF
4y 4m to grant Granted Sep 22, 2026
Patent 12697564
Dephosphorylation-controlled extraction of phosphorylatable psychoactive alkaloids
2y 10m to grant Granted Aug 04, 2026
Patent 12673114
COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING IL-2 SURFACE EXPRESSION-EXTRACELLULAR VESICLES AS ACTIVE INGREDIENT
4y 6m to grant Granted Jul 07, 2026
Patent 12622869
LIPID EMULSION FOR PARENTERAL ADMINISTRATION
5y 4m to grant Granted May 12, 2026
Patent 12616707
COMPOSITIONS AND METHODS FOR IMPROVING GUT HEALTH
2y 11m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
37%
Grant Probability
55%
With Interview (+18.0%)
4y 3m (~2y 4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 791 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month